Tag: prnewswire

SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- To address the growing need for competitive talent retention among small and medium-sized enterprises (SMEs), ...

Chula Researchers Develop Synthetic Boar Scent Mimicking Natural Pheromones to Reduce Disease Outbreak Risks in Pig Farms

BANGKOK, Aug. 31, 2026 /PRNewswire/ -- Researchers from Chulalongkorn University's Faculty of Veterinary Science have developed synthetic boar scent mimicking natural ...

Dowinx Reframes Everyday Seating Around the Way People Really Live

The QL-66B6 Executive Office Chair brings adaptive comfort to hybrid spaces for work, gaming and relaxation HONG KONG and LOS ...

AU10TIX and NEO Partner to Bring Real-Time Identity Verification to High-Volume Venues

Partnership helps gaming, wagering, hospitality, and travel operators automate identity checks, reduce manual review, and accelerate compliant self-service experiences MELBOURNE, ...

LG ELECTRONICS UNVEILS THE NEXT EVOLUTION OF AI HOME AT IFA 2026

Introducing ThinQ Claw and Expanded AI Home Experiences Powered by Contextual Intelligence News Summary LG unveils the next evolution of ...

NUS-ISS Learning Festival 2026 addresses key blockers to enterprise AI: data readiness, governance, and workforce capability

From expert keynotes and practical workshops to a hackathon, this year's festival equips participants with practical insights to move from ...

Amai Proteins’ sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage Products

Third regulatory approval in less than six months enables food and beverage manufacturers to commercialize products sweetened with sweelin® in ...

$Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore$

Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore

Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 ...

WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion

SHANGHAI, Aug. 31, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, ...

Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research